|
Related Links
| Contact Us Toll Free |
| Global |
1 866 629 7100 |
| Local |
402 697 6500 |
| E-mail |
General Inquires |
|
|
Our modern Phase I facility in Omaha, NE is equipped to implement rapid project initiation. Qualia has the resources to accommodate studies ranging from bioavailability/bioequivalence to those requiring IV dosing and intensive monitoring.
Qualia has expertise in multiple study areas, including first-in-human and proof-of-concept, single and multiple rising dose tolerance, drug-drug interaction, pharmacokinetic/pharmacodynamic, cardiac safety, food effect, specialized gastroenterology, CNS/psychopharmacology, and PK in special populations.
We cultivate relationships within the medical community allowing Qualia to target patient populations with speed and confidence. Our Physician Network allows access to many populations that cannot be obtained in other regions. Innovation is the key to effective participant recruitment, and Qualia utilizes progressive recruitment techniques in order to reach targets effectively.
|
The Omaha Phase I facility is experiencing explosive growth in database size due to innovative recruiting techniques. In the first ten months of 2007, the database grew nearly 30% each month. Qualia will continue actively recruiting in order to maintain a large and active database of participants with different demographics and health profiles.
|
Modern Facility
- 33,000 square foot facility with 160 beds (including 22 hospital beds)
- Minutes away from major hospitals
- Nine hospitals and three medical centers in Omaha
- Short & Long-term confinement accommodations
- Modern study participant amenities (technology, recreation, and lounging)
- Dedicated screening and outpatient areas
- Satellite-synchronized digital clocks
- Continuously monitored refrigerators, freezers and refrigerated centrifuges -20°C freezers and -80°C freezers
- Secure card key access
- Controlled-access pharmacy (humidity & temperature monitored)
- Controlled-access data storage room
- Comprehensive fire suppression system
- Hard-wired emergency back-up generator
- Lab partnership with the largest regional reference laboratory in the Midwest
- 12-lead telemetry
- ECG machines
- Automated BP and vital sign monitors
- Glucometers for glucose monitoring
- Crash carts equipped with defibrillator, oxygen tanks, Ambu Bags and emergency medications
- Partnerships with eResearch Technology, Biomedical Systems, and Mortara Instrument
Early Phase
- First-in-human and proof-of-concept studies
- Single and multiple rising dose tolerance
- Drug-drug interaction
- PK/PD studies
- Cardiac safety studies (i.e. thorough QT/QTc studies)
- PK in special populations (elderly, postmenopausal, rheumatoid arthritis, and gender specific)
- Bioavailability and Bioequivalence studies
- Food effect
- Hepatic and renal impaired studies
- Specialized GI studies
- CNS/psycho pharmacology
Learn More About Omaha
|
|